Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Asset Utilization Ratio (2021 - 2025)

Cytek Biosciences (CTKB) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.4 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio changed N/A year-over-year to 0.4, compared with a TTM value of 0.4 through Sep 2025, changed N/A, and an annual FY2024 reading of 0.4, up 5.94% over the prior year.
  • Asset Utilization Ratio was 0.4 for Q3 2025 at Cytek Biosciences, down from 0.41 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.41 in Q1 2024 and bottomed at 0.08 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.31, with a median of 0.32 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio surged 287.27% in 2022, then increased 8.81% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.28 in 2021, then rose by 15.47% to 0.32 in 2022, then increased by 18.23% to 0.38 in 2023, then rose by 6.91% to 0.41 in 2024, then fell by 2.14% to 0.4 in 2025.
  • Business Quant data shows Asset Utilization Ratio for CTKB at 0.4 in Q3 2025, 0.41 in Q1 2024, and 0.38 in Q4 2023.